1. About.com
  2. Health
  3. Arthritis & Joint Conditions

Nifedipine - Adalat - Dosage - Side Effects - Interactions - Warnings

Nifedipine (Adalat, Adalat CC, Afeditab CR, Nifediac CC, Nifedical XL, Procardia, Procardia XL) drug information, dosage, side effects, drug interactions, and warnings. Nifedipine, brand name drugs include Adalat, Adalat CC, Afeditab CR, Nifediac CC, Nifedical XL, Procardia, and Procardia XL, helps relax blood vessels and is used to relieve symptoms of Raynaud's phenomenon.
  1. A - Z: Arthritis Drugs
  2. A - Z: Drug Costs
  3. A - Z: Drug Side Effects
  4. Raynaud's Phenomenon

Drugs A-Z - Adalat, Procardia / Nifedipine Capsules

Patient education for Adalat, Procardia / nifedipine capsules.

Raynaud's Phenomenon Screening Quiz

Raynaud's phenomenon can occur as a primary condition or secondary condition (for example, along with rheumatoid arthritis, lupus, scleroderma). The primary characteristic is cold and discolored fingers and toes. Take the Raynaud's Phenomenon Screening Quiz.

Guide to Raynaud's Phenomenon

A three-part guide to the causes, symptoms, diagnosis, and treatment of Raynaud's phenomenon, a disorder that affects the blood vessels in the fingers, toes, ears, and nose. Raynaud's phenomenon can be primary, or secondary to other conditions such as scleroderma, lupus, mixed connective tissue disease, Sjogren's syndrome, dermatomyositis, and polymyositis.

Understanding Raynaud's Phenomenon

Raynaud's Phenomenon can exist as a primary condition or in congruence with an underlying disease, most commonly one of the connective tissue diseases.

Drug Profile: Nifedipine / Adalat, Adalat CC, Procardia, Procardia XL

Drug profile and essential information for Nifedipine (Adalat, Adalat CC, Procardia, Procardia XL) Nifedipine interferes with the movement of calcium into heart muscle cells and the smooth muscle cells in the walls of the arteries. This action relaxes blood vessels (causing them to widen), from UMM.

Discuss in my forum

©2012 About.com. All rights reserved. 

A part of The New York Times Company.

We comply with the HONcode standard
for trustworthy health
information: verify here.